Clinical Trial Update: Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two iodinated contrast media in patients at risk of renal impairment undergoing CT evaluated renal effects; the study was terminated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus

Drugs mentioned

• OMNIPAQUE (iohexol)
• VISIPAQUE (IODIXANOL)

Snippet

Sponsor: GE Healthcare | Conditions: Renal Insufficiency, Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2014-10-10